Cargando…
γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer
Immune checkpoint blockade has been largely unsuccessful for the treatment of bone metastatic castrate-resistant prostate cancer (mCRPC). Here, we report a combinatorial strategy to treat mCRPC using γδ-enriched chimeric antigen receptor (CAR) T cells and zoledronate (ZOL). In a preclinical murine m...
Autores principales: | Frieling, Jeremy S., Tordesillas, Leticia, Bustos, Xiomar E., Ramello, Maria Cecilia, Bishop, Ryan T., Cianne, Junior E., Snedal, Sebastian A., Li, Tao, Lo, Chen Hao, de la Iglesia, Janis, Roselli, Emiliano, Benzaïd, Ismahène, Wang, Xuefeng, Kim, Youngchul, Lynch, Conor C., Abate-Daga, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156127/ https://www.ncbi.nlm.nih.gov/pubmed/37134157 http://dx.doi.org/10.1126/sciadv.adf0108 |
Ejemplares similares
-
Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells
por: Potez, Marine, et al.
Publicado: (2023) -
CAR models: next-generation CAR modifications for enhanced T-cell function
por: Abate-Daga, Daniel, et al.
Publicado: (2016) -
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
por: Rodriguez-Marquez, Paula, et al.
Publicado: (2022) -
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
por: Rejeski, Kai, et al.
Publicado: (2023) -
Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans
por: Chen, Xu, et al.
Publicado: (2022)